25 XP   0   0   10

Oscotec Inc
Buy, Hold or Sell?

Let's analyse Oscotec together

PenkeI guess you are interested in Oscotec Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oscotec Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oscotec Inc

I send you an email if I find something interesting about Oscotec Inc.

Quick analysis of Oscotec (30 sec.)










What can you expect buying and holding a share of Oscotec? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,493.62
Expected worth in 1 year
₩1,653.03
How sure are you?
41.0%

+ What do you gain per year?

Total Gains per Share
₩-840.59
Return On Investment
-2.8%

For what price can you sell your share?

Current Price per Share
₩30,200.00
Expected price per share
₩29,800 - ₩34,200
How sure are you?
50%

1. Valuation of Oscotec (5 min.)




Live pricePrice per Share (EOD)

₩30,200.00

Intrinsic Value Per Share

₩13,024.45 - ₩15,988.55

Total Value Per Share

₩15,518.07 - ₩18,482.17

2. Growth of Oscotec (5 min.)




Is Oscotec growing?

Current yearPrevious yearGrowGrow %
How rich?$66.3m$40m$35.7m47.1%

How much money is Oscotec making?

Current yearPrevious yearGrowGrow %
Making money-$4.2m-$4.2m$26.2k0.6%
Net Profit Margin-1,103.5%-507.0%--

How much money comes from the company's main activities?

3. Financial Health of Oscotec (5 min.)




4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

What can you expect buying and holding a share of Oscotec? (5 min.)

Welcome investor! Oscotec's management wants to use your money to grow the business. In return you get a share of Oscotec.

What can you expect buying and holding a share of Oscotec?

First you should know what it really means to hold a share of Oscotec. And how you can make/lose money.

Speculation

The Price per Share of Oscotec is ₩30,200. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oscotec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oscotec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,493.62. Based on the TTM, the Book Value Change Per Share is ₩-210.15 per quarter. Based on the YOY, the Book Value Change Per Share is ₩605.95 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oscotec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.200.0%-0.110.0%-0.130.0%-0.110.0%-0.060.0%
Usd Book Value Change Per Share-0.240.0%-0.150.0%0.420.0%0.020.0%0.030.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.240.0%-0.150.0%0.420.0%0.020.0%0.030.0%
Usd Price Per Share16.14-16.38-16.03-20.39-13.83-
Price to Earnings Ratio-20.61--42.59--30.93--24.67--31.58-
Price-to-Total Gains Ratio-66.17--124.89--52.47--79.85--67.38-
Price to Book Ratio9.24-8.24-20.05-19.51-15.92-
Price-to-Total Gains Ratio-66.17--124.89--52.47--79.85--67.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share21.14
Number of shares47
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.150.02
Usd Total Gains Per Share-0.150.02
Gains per Quarter (47 shares)-6.911.08
Gains per Year (47 shares)-27.664.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-28-3804-6
20-55-6609-2
30-83-940132
40-111-1220176
50-138-15002210
60-166-17802614
70-194-20603018
80-221-23403422
90-249-26203926
100-277-29004330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%5.023.011.012.8%6.023.014.014.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%16.023.00.041.0%18.025.00.041.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.039.00.0%0.00.043.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%16.023.00.041.0%18.025.00.041.9%

Fundamentals of Oscotec

About Oscotec Inc

Oscotec Inc. operates as a clinical stage drug discovery and development company. It develops SYK inhibitor that is in Phase IIa clinical trial to treat rheumatoid arthritis and immune thrombocytopenia; FLT3 inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia; and EGFR double mutation inhibitor to treat non-small cell lung cancer, as well as Anti-Tau antibody, which is in preclinical Phase for the treatment of Alzheimer's disease. The company also offers dental health products, such as bone graft comprising InduCera, BioCera-F, and SynCeraII; and membrane consisting of LysoGide and CollaGuide. In addition, it provides functional ingredients comprises OPB for osteoporosis; AIF for arthritis; SGA that enhance bone growth; and PRF-K for perio diseases. The company was formerly known as Oscotec Co., Ltd and changed its name to Oscotec Inc. in June 1999. Oscotec Inc. was founded in 1988 and is based in Seongnam, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 06:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oscotec Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oscotec earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • A Net Profit Margin of -3,473.3% means that ₩-34.73 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oscotec Inc:

  • The MRQ is -3,473.3%. The company is making a huge loss. -2
  • The TTM is -1,103.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,473.3%TTM-1,103.5%-2,369.8%
TTM-1,103.5%YOY-507.0%-596.4%
TTM-1,103.5%5Y-643.1%-460.4%
5Y-643.1%10Y-356.8%-286.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,473.3%9.4%-3,482.7%
TTM-1,103.5%9.4%-1,112.9%
YOY-507.0%10.3%-517.3%
5Y-643.1%12.1%-655.2%
10Y-356.8%11.7%-368.5%
1.1.2. Return on Assets

Shows how efficient Oscotec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • -8.0% Return on Assets means that Oscotec generated ₩-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oscotec Inc:

  • The MRQ is -8.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.0%TTM-4.5%-3.5%
TTM-4.5%YOY-10.0%+5.5%
TTM-4.5%5Y-7.2%+2.8%
5Y-7.2%10Y-3.8%-3.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%5.5%-13.5%
TTM-4.5%5.7%-10.2%
YOY-10.0%5.6%-15.6%
5Y-7.2%5.7%-12.9%
10Y-3.8%6.2%-10.0%
1.1.3. Return on Equity

Shows how efficient Oscotec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • -10.7% Return on Equity means Oscotec generated ₩-0.11 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oscotec Inc:

  • The MRQ is -10.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-5.7%-5.0%
TTM-5.7%YOY-17.1%+11.5%
TTM-5.7%5Y-11.5%+5.8%
5Y-11.5%10Y-6.1%-5.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.7%8.2%-18.9%
TTM-5.7%8.8%-14.5%
YOY-17.1%8.1%-25.2%
5Y-11.5%8.4%-19.9%
10Y-6.1%11.2%-17.3%

1.2. Operating Efficiency of Oscotec Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oscotec is operating .

  • Measures how much profit Oscotec makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oscotec Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-485.5%+485.5%
TTM-5Y-394.8%+394.8%
5Y-394.8%10Y-235.7%-159.1%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%-11.9%
TTM-11.4%-11.4%
YOY-485.5%13.8%-499.3%
5Y-394.8%11.9%-406.7%
10Y-235.7%13.2%-248.9%
1.2.2. Operating Ratio

Measures how efficient Oscotec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 35.99 means that the operating costs are ₩35.99 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Oscotec Inc:

  • The MRQ is 35.994. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.642. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ35.994TTM12.642+23.353
TTM12.642YOY1.719+10.923
TTM12.6425Y4.352+8.290
5Y4.35210Y2.950+1.401
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ35.9941.314+34.680
TTM12.6421.311+11.331
YOY1.7191.242+0.477
5Y4.3521.241+3.111
10Y2.9501.210+1.740

1.3. Liquidity of Oscotec Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oscotec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 2.94 means the company has ₩2.94 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Oscotec Inc:

  • The MRQ is 2.939. The company is able to pay all its short-term debts. +1
  • The TTM is 4.166. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.939TTM4.166-1.227
TTM4.166YOY2.548+1.618
TTM4.1665Y3.030+1.136
5Y3.03010Y1.983+1.047
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9391.959+0.980
TTM4.1661.959+2.207
YOY2.5482.156+0.392
5Y3.0302.109+0.921
10Y1.9832.053-0.070
1.3.2. Quick Ratio

Measures if Oscotec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • A Quick Ratio of 2.62 means the company can pay off ₩2.62 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oscotec Inc:

  • The MRQ is 2.620. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.193. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.620TTM6.193-3.572
TTM6.193YOY4.264+1.928
TTM6.1935Y3.743+2.449
5Y3.74310Y2.237+1.506
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6201.514+1.106
TTM6.1931.463+4.730
YOY4.2641.623+2.641
5Y3.7431.702+2.041
10Y2.2371.339+0.898

1.4. Solvency of Oscotec Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oscotec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oscotec to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.29 means that Oscotec assets are financed with 28.6% credit (debt) and the remaining percentage (100% - 28.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oscotec Inc:

  • The MRQ is 0.286. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.212. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.286TTM0.212+0.074
TTM0.212YOY0.332-0.120
TTM0.2125Y0.314-0.102
5Y0.31410Y0.328-0.015
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2860.333-0.047
TTM0.2120.333-0.121
YOY0.3320.321+0.011
5Y0.3140.322-0.008
10Y0.3280.346-0.018
1.4.2. Debt to Equity Ratio

Measures if Oscotec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oscotec to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 38.3% means that company has ₩0.38 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oscotec Inc:

  • The MRQ is 0.383. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.268. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.383TTM0.268+0.115
TTM0.268YOY0.554-0.286
TTM0.2685Y0.490-0.222
5Y0.49010Y0.535-0.045
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3830.499-0.116
TTM0.2680.499-0.231
YOY0.5540.475+0.079
5Y0.4900.503-0.013
10Y0.5350.542-0.007

2. Market Valuation of Oscotec Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Oscotec generates.

  • Above 15 is considered overpriced but always compare Oscotec to the Pharmaceuticals industry mean.
  • A PE ratio of -20.61 means the investor is paying ₩-20.61 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oscotec Inc:

  • The EOD is -27.003. Based on the earnings, the company is expensive. -2
  • The MRQ is -20.610. Based on the earnings, the company is expensive. -2
  • The TTM is -42.593. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-27.003MRQ-20.610-6.393
MRQ-20.610TTM-42.593+21.983
TTM-42.593YOY-30.931-11.661
TTM-42.5935Y-24.666-17.927
5Y-24.66610Y-31.584+6.918
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-27.00329.850-56.853
MRQ-20.61023.095-43.705
TTM-42.59323.095-65.688
YOY-30.93123.459-54.390
5Y-24.66626.701-51.367
10Y-31.58427.097-58.681
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oscotec Inc:

  • The EOD is -179.779. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -137.215. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -58.234. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-179.779MRQ-137.215-42.564
MRQ-137.215TTM-58.234-78.981
TTM-58.234YOY-27.537-30.698
TTM-58.2345Y-8.120-50.114
5Y-8.12010Y-24.403+16.282
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-179.77934.066-213.845
MRQ-137.21520.307-157.522
TTM-58.23432.204-90.438
YOY-27.53730.093-57.630
5Y-8.12025.530-33.650
10Y-24.40327.257-51.660
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oscotec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 9.24 means the investor is paying ₩9.24 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Oscotec Inc:

  • The EOD is 12.111. Based on the equity, the company is expensive. -2
  • The MRQ is 9.244. Based on the equity, the company is overpriced. -1
  • The TTM is 8.235. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD12.111MRQ9.244+2.867
MRQ9.244TTM8.235+1.008
TTM8.235YOY20.051-11.816
TTM8.2355Y19.511-11.276
5Y19.51110Y15.920+3.591
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD12.1113.754+8.357
MRQ9.2442.328+6.916
TTM8.2352.473+5.762
YOY20.0512.944+17.107
5Y19.5113.317+16.194
10Y15.9203.878+12.042
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Oscotec Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---348.337-210.146-40%605.946-157%32.749-1164%43.715-897%
Book Value Per Share--2493.6182880.739-13%1690.003+48%1809.145+38%1388.696+80%
Current Ratio--2.9394.166-29%2.548+15%3.030-3%1.983+48%
Debt To Asset Ratio--0.2860.212+35%0.332-14%0.314-9%0.328-13%
Debt To Equity Ratio--0.3830.268+43%0.554-31%0.490-22%0.535-29%
Dividend Per Share----0%-0%-0%-0%
Eps---279.602-161.085-42%-190.373-32%-162.203-42%-79.677-72%
Free Cash Flow Per Share---41.996-150.214+258%-214.928+412%-147.663+252%-95.798+128%
Free Cash Flow To Equity Per Share---41.996-99.415+137%849.467-105%120.337-135%122.910-134%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.718+39%
Intrinsic Value_10Y_max--15988.551--------
Intrinsic Value_10Y_min--13024.447--------
Intrinsic Value_1Y_max---342.456--------
Intrinsic Value_1Y_min---337.518--------
Intrinsic Value_3Y_max--453.085--------
Intrinsic Value_3Y_min--402.634--------
Intrinsic Value_5Y_max--3035.368--------
Intrinsic Value_5Y_min--2689.795--------
Market Cap848674360000.000-3%875530231900.000882066346950.000-1%740332065256.931+18%900291227486.491-3%632983129533.906+38%
Net Profit Margin---34.733-11.035-68%-5.070-85%-6.431-81%-3.568-90%
Operating Margin----0%-4.8550%-3.9480%-2.3570%
Operating Ratio--35.99412.642+185%1.719+1994%4.352+727%2.950+1120%
Pb Ratio12.111+24%9.2448.235+12%20.051-54%19.511-53%15.920-42%
Pe Ratio-27.003-31%-20.610-42.593+107%-30.931+50%-24.666+20%-31.584+53%
Price Per Share30200.000+24%23050.00023395.000-1%22900.013+1%29124.021-21%19750.913+17%
Price To Free Cash Flow Ratio-179.779-31%-137.215-58.234-58%-27.537-80%-8.120-94%-24.403-82%
Price To Total Gains Ratio-86.698-31%-66.171-124.893+89%-52.467-21%-79.853+21%-67.383+2%
Quick Ratio--2.6206.193-58%4.264-39%3.743-30%2.237+17%
Return On Assets---0.080-0.045-44%-0.100+25%-0.072-10%-0.038-53%
Return On Equity---0.107-0.057-47%-0.171+60%-0.115+7%-0.061-43%
Total Gains Per Share---348.337-210.146-40%605.946-157%32.749-1164%43.715-897%
Usd Book Value--66302240.24275817327.311-13%40088356.679+65%41154613.435+61%30771819.430+115%
Usd Book Value Change Per Share---0.244-0.147-40%0.424-157%0.023-1164%0.031-897%
Usd Book Value Per Share--1.7462.017-13%1.183+48%1.266+38%0.972+80%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.196-0.113-42%-0.133-32%-0.114-42%-0.056-72%
Usd Free Cash Flow---1116622.983-3960055.845+255%-4842272.792+334%-3255694.964+192%-1731665.982+55%
Usd Free Cash Flow Per Share---0.029-0.105+258%-0.150+412%-0.103+252%-0.067+128%
Usd Free Cash Flow To Equity Per Share---0.029-0.070+137%0.595-105%0.084-135%0.086-134%
Usd Market Cap594072052.000-3%612871162.330617446442.865-1%518232445.680+18%630203859.241-3%443088190.674+38%
Usd Price Per Share21.140+24%16.13516.377-1%16.030+1%20.387-21%13.826+17%
Usd Profit---7434271.761-4248917.043-43%-4275170.373-42%-3561731.223-52%-1798436.287-76%
Usd Revenue--214042.066866412.748-75%885915.888-76%2161437.409-90%2282362.673-91%
Usd Total Gains Per Share---0.244-0.147-40%0.424-157%0.023-1164%0.031-897%
 EOD+3 -5MRQTTM+8 -24YOY+16 -165Y+13 -1910Y+17 -16

3.2. Fundamental Score

Let's check the fundamental score of Oscotec Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-27.003
Price to Book Ratio (EOD)Between0-112.111
Net Profit Margin (MRQ)Greater than0-34.733
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.620
Current Ratio (MRQ)Greater than12.939
Debt to Asset Ratio (MRQ)Less than10.286
Debt to Equity Ratio (MRQ)Less than10.383
Return on Equity (MRQ)Greater than0.15-0.107
Return on Assets (MRQ)Greater than0.05-0.080
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Oscotec Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.372
Ma 20Greater thanMa 5028,437.500
Ma 50Greater thanMa 10026,304.000
Ma 100Greater thanMa 20023,384.500
OpenGreater thanClose30,650.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  760,909-9,179751,729506,7551,258,485-121,3861,137,098-1,363,767-226,669



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets132,578,400
Total Liabilities37,860,914
Total Stockholder Equity98,918,426
 As reported
Total Liabilities 37,860,914
Total Stockholder Equity+ 98,918,426
Total Assets = 132,578,400

Assets

Total Assets132,578,400
Total Current Assets102,428,704
Long-term Assets30,149,696
Total Current Assets
Cash And Cash Equivalents 7,951,489
Short-term Investments 89,529,107
Net Receivables 1,785,166
Inventory 1,700,686
Other Current Assets 0
Total Current Assets  (as reported)102,428,704
Total Current Assets  (calculated)100,966,448
+/- 1,462,255
Long-term Assets
Property Plant Equipment 18,054,437
Intangible Assets 595,276
Long-term Assets Other 0
Long-term Assets  (as reported)30,149,696
Long-term Assets  (calculated)18,649,713
+/- 11,499,984

Liabilities & Shareholders' Equity

Total Current Liabilities34,849,044
Long-term Liabilities3,011,870
Total Stockholder Equity98,918,426
Total Current Liabilities
Short Long Term Debt 6,187,740
Accounts payable 895,617
Other Current Liabilities 1
Total Current Liabilities  (as reported)34,849,044
Total Current Liabilities  (calculated)7,083,358
+/- 27,765,686
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt164,254
Long-term Liabilities  (as reported)3,011,870
Long-term Liabilities  (calculated)164,254
+/- 2,847,616
Total Stockholder Equity
Total Stockholder Equity (as reported)98,918,426
Total Stockholder Equity (calculated)0
+/- 98,918,426
Other
Capital Stock19,092,559
Common Stock Shares Outstanding 37,984
Net Invested Capital 105,005,586
Net Working Capital 67,579,659
Property Plant and Equipment Gross 24,627,870



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
42,928,268
41,683,035
41,058,153
37,647,732
37,438,209
37,178,402
37,229,662
36,269,210
37,947,526
38,397,656
40,491,180
49,498,623
48,886,407
37,761,850
41,240,915
40,813,572
40,144,520
39,705,957
39,227,003
54,856,229
38,543,211
37,842,572
53,593,057
70,258,505
64,734,980
64,002,120
60,070,650
72,393,422
68,473,987
73,424,890
63,389,140
76,387,768
67,416,166
57,639,846
58,317,531
48,967,315
43,325,217
66,882,856
61,202,060
143,735,698
139,717,866
138,496,443
138,182,591
132,578,400
132,578,400138,182,591138,496,443139,717,866143,735,69861,202,06066,882,85643,325,21748,967,31558,317,53157,639,84667,416,16676,387,76863,389,14073,424,89068,473,98772,393,42260,070,65064,002,12064,734,98070,258,50553,593,05737,842,57238,543,21154,856,22939,227,00339,705,95740,144,52040,813,57241,240,91537,761,85048,886,40749,498,62340,491,18038,397,65637,947,52636,269,21037,229,66237,178,40237,438,20937,647,73241,058,15341,683,03542,928,268
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,976,872
29,543,251
27,677,316
26,903,446
42,670,597
57,317,004
51,669,730
47,236,857
42,824,648
55,271,847
48,646,571
52,424,379
42,614,886
54,966,041
44,390,737
34,768,787
25,454,772
16,990,417
11,661,698
34,958,963
28,487,823
107,871,878
108,789,352
107,436,066
107,357,017
102,428,704
102,428,704107,357,017107,436,066108,789,352107,871,87828,487,82334,958,96311,661,69816,990,41725,454,77234,768,78744,390,73754,966,04142,614,88652,424,37948,646,57155,271,84742,824,64847,236,85751,669,73057,317,00442,670,59726,903,44627,677,31629,543,25114,976,872000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,951,724
19,707,706
18,395,307
17,897,337
25,852,337
26,363,208
29,518,243
34,928,954
28,556,534
49,234,502
37,722,598
8,235,975
14,406,754
5,786,917
10,123,295
17,853,979
10,912,619
10,581,668
43
83
15
53
79
129
7,478,360
7,951,489
7,951,4897,478,360129795315834310,581,66810,912,61917,853,97910,123,2955,786,91714,406,7548,235,97537,722,59849,234,50228,556,53434,928,95429,518,24326,363,20825,852,33717,897,33718,395,30719,707,7061,951,724000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,558,540
4,058,033
3,361,034
3,252,837
11,228,235
9,295,432
8,314,007
6,444,169
8,922,125
3,483,034
0
0
0
22,343,026
5,988,423
14,694,969
11,779,707
4,002,780
0
21,162,800
13,556,011
98,172,035
103,527,701
97,580,018
91,966,169
89,529,107
89,529,10791,966,16997,580,018103,527,70198,172,03513,556,01121,162,80004,002,78011,779,70714,694,9695,988,42322,343,0260003,483,0348,922,1256,444,1698,314,0079,295,43211,228,2353,252,8373,361,0344,058,0336,558,540000000000000000000
       Net Receivables 
4,449,516
4,471,426
4,529,910
2,941,982
3,494,521
3,418,999
3,642,104
3,275,744
3,607,210
3,426,510
4,021,463
3,837,323
3,479,015
0
5,289,233
5,647,901
4,855,060
4,725,368
4,733,562
3,912,243
4,143,974
3,847,174
3,747,066
19,217,163
11,069,287
1,629,189
859,953
765,698
732,219
15,731,980
505,454
25,158,122
26,354,166
587,654
1,100,034
662,516
982,561
1,879,893
1,990,277
1,606,372
792,199
1,739,344
2,652,318
1,785,166
1,785,1662,652,3181,739,344792,1991,606,3721,990,2771,879,893982,561662,5161,100,034587,65426,354,16625,158,122505,45415,731,980732,219765,698859,9531,629,18911,069,28719,217,1633,747,0663,847,1744,143,9743,912,2434,733,5624,725,3684,855,0605,647,9015,289,23303,479,0153,837,3234,021,4633,426,5103,607,2103,275,7443,642,1043,418,9993,494,5212,941,9824,529,9104,471,4264,449,516
       Other Current Assets 
534,268
726,408
844,879
658,532
801,081
931,868
798,244
924,761
1,086,777
1,332,649
1,532,524
1,117,198
1,008,188
6,647,982
988,479
910,771
975,590
964,735
955,490
976,357
804,485
902,734
749,031
1,281,906
1,518,543
3,081,708
383,701
632,575
564,995
394,121
743,583
487,442
661,079
373,734
352,661
418,497
449,798
431,891
551,779
1
0
0
0
0
00001551,779431,891449,798418,497352,661373,734661,079487,442743,583394,121564,995632,575383,7013,081,7081,518,5431,281,906749,031902,734804,485976,357955,490964,735975,590910,771988,4796,647,9821,008,1881,117,1981,532,5241,332,6491,086,777924,761798,244931,868801,081658,532844,879726,408534,268
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,863,820
30,928,514
31,060,377
30,825,573
30,149,696
30,149,69630,825,57331,060,37730,928,51435,863,820000000000000000000000000000000000000000
       Property Plant Equipment 
9,475,208
9,384,581
9,282,921
9,196,341
9,220,739
9,107,895
9,140,185
9,086,264
9,005,979
8,958,280
8,893,539
8,867,362
8,778,300
8,542,028
8,495,857
8,439,207
8,405,582
8,366,771
8,317,725
9,487,522
9,488,635
9,577,177
9,528,143
11,545,194
11,553,524
15,008,685
15,486,839
15,548,041
17,781,118
17,044,693
11,737,394
12,823,736
13,028,075
12,848,509
13,330,022
23,240,399
23,044,308
19,094,949
19,660,609
19,147,336
18,951,127
18,810,741
18,617,546
18,054,437
18,054,43718,617,54618,810,74118,951,12719,147,33619,660,60919,094,94923,044,30823,240,39913,330,02212,848,50913,028,07512,823,73611,737,39417,044,69317,781,11815,548,04115,486,83915,008,68511,553,52411,545,1949,528,1439,577,1779,488,6359,487,5228,317,7258,366,7718,405,5828,439,2078,495,8578,542,0288,778,3008,867,3628,893,5398,958,2809,005,9799,086,2649,140,1859,107,8959,220,7399,196,3419,282,9219,384,5819,475,208
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,999
24,000
29,999
36,000
41,999
47,999
53,999
61,999
67,999
73,998
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000073,99867,99961,99953,99947,99941,99936,00029,99924,00017,999000000000000000000
       Intangible Assets 
2,083,086
1,791,879
1,741,596
1,743,499
1,752,957
1,691,513
1,757,154
1,816,522
1,824,575
1,844,877
1,931,736
1,901,467
1,867,284
366,126
365,606
571,459
540,993
557,872
562,018
528,948
612,919
629,025
670,472
672,269
665,364
1,035,500
1,431,537
1,441,330
1,499,989
1,521,286
1,499,791
1,227,505
1,227,187
1,245,776
1,278,507
1,246,972
1,232,519
1,259,293
1,306,866
590,282
624,877
625,529
576,564
595,276
595,276576,564625,529624,877590,2821,306,8661,259,2931,232,5191,246,9721,278,5071,245,7761,227,1871,227,5051,499,7911,521,2861,499,9891,441,3301,431,5371,035,500665,364672,269670,472629,025612,919528,948562,018557,872540,993571,459365,606366,1261,867,2841,901,4671,931,7361,844,8771,824,5751,816,5221,757,1541,691,5131,752,9571,743,4991,741,5961,791,8792,083,086
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000
> Total Liabilities 
17,469,273
16,036,572
15,762,342
15,482,382
13,797,669
13,883,752
13,988,301
14,486,008
13,558,129
14,188,318
14,672,686
22,580,646
20,617,981
15,055,311
14,265,957
12,052,584
11,892,056
8,340,265
7,576,185
14,891,654
13,916,108
14,106,403
23,574,604
18,589,269
17,377,807
23,653,256
27,491,098
21,105,079
23,240,642
21,251,925
18,198,017
23,337,748
22,897,991
18,216,104
24,780,494
20,139,750
22,006,680
21,152,985
21,682,507
21,227,336
22,537,068
25,101,572
30,233,875
37,860,914
37,860,91430,233,87525,101,57222,537,06821,227,33621,682,50721,152,98522,006,68020,139,75024,780,49418,216,10422,897,99123,337,74818,198,01721,251,92523,240,64221,105,07927,491,09823,653,25617,377,80718,589,26923,574,60414,106,40313,916,10814,891,6547,576,1858,340,26511,892,05612,052,58414,265,95715,055,31120,617,98122,580,64614,672,68614,188,31813,558,12914,486,00813,988,30113,883,75213,797,66915,482,38215,762,34216,036,57217,469,273
   > Total Current Liabilities 
11,569,540
12,712,689
12,859,453
12,610,560
11,082,732
10,993,837
11,044,108
11,608,190
10,827,991
11,383,416
11,768,305
21,763,718
17,438,081
11,983,491
11,148,092
8,910,724
8,752,048
5,068,005
4,297,687
11,723,533
10,741,056
11,029,037
20,592,841
15,722,445
14,592,114
20,528,238
20,496,674
14,416,461
16,819,669
14,371,330
12,467,899
15,543,810
15,197,822
11,529,038
18,542,524
14,442,311
16,958,592
16,600,865
17,891,617
18,574,496
20,694,917
23,710,367
27,266,698
34,849,044
34,849,04427,266,69823,710,36720,694,91718,574,49617,891,61716,600,86516,958,59214,442,31118,542,52411,529,03815,197,82215,543,81012,467,89914,371,33016,819,66914,416,46120,496,67420,528,23814,592,11415,722,44520,592,84111,029,03710,741,05611,723,5334,297,6875,068,0058,752,0488,910,72411,148,09211,983,49117,438,08121,763,71811,768,30511,383,41610,827,99111,608,19011,044,10810,993,83711,082,73212,610,56012,859,45312,712,68911,569,540
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
902,848
8,149,915
198,200
8,735,449
16,146,992
7,489,799
7,760,666
396,360
1,900,000
1,100,000
2,567,120
1,440,840
0
0
0
0
6,000,000
6,000,000
6,000,000
7,551,480
7,721,760
9,294,980
10,954,440
6,000,000
0
0
006,000,00010,954,4409,294,9807,721,7607,551,4806,000,0006,000,0006,000,00000001,440,8402,567,1201,100,0001,900,000396,3607,760,6667,489,79916,146,9928,735,449198,2008,149,915902,848000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
902,848
8,149,915
198,200
8,735,449
16,146,992
7,489,799
7,760,666
396,360
396,360
375,480
0
0
0
0
0
0
0
0
0
0
0
9,670,460
11,329,920
6,375,480
6,375,480
6,187,740
6,187,7406,375,4806,375,48011,329,9209,670,46000000000000375,480396,360396,3607,760,6667,489,79916,146,9928,735,449198,2008,149,915902,848000000000000000000
       Accounts payable 
1,950,835
3,762,667
3,305,095
2,413,321
1,696,068
2,001,628
1,652,975
1,886,799
1,651,841
2,273,217
2,401,627
3,857,040
0
0
803,298
110,148
49,854
53,213
98,548
94,402
112,453
144,949
172,724
355,656
167,690
313,282
390,087
202,782
1,345,096
226,058
244,378
315,219
583,014
260,045
382,217
310,162
521,830
413,792
392,886
705,579
734,998
444,557
672,234
895,617
895,617672,234444,557734,998705,579392,886413,792521,830310,162382,217260,045583,014315,219244,378226,0581,345,096202,782390,087313,282167,690355,656172,724144,949112,45394,40298,54853,21349,854110,148803,298003,857,0402,401,6272,273,2171,651,8411,886,7991,652,9752,001,6281,696,0682,413,3213,305,0953,762,6671,950,835
       Other Current Liabilities 
574,581
1,002,477
1,283,369
711,632
805,441
643,424
690,100
549,240
618,724
340,016
324,739
600,368
2,963,282
1,071,914
311,238
333,392
222,958
279,547
214,178
472,102
246,991
226,029
2,353,471
5,785,127
3,626,216
10,008,791
9,604,563
8,770,985
8,447,048
8,001,323
7,536,377
9,175,967
8,813,334
6,068,964
6,465,841
6,610,297
9,476,948
6,632,628
7,685,126
-1
0
0
0
1
1000-17,685,1266,632,6289,476,9486,610,2976,465,8416,068,9648,813,3349,175,9677,536,3778,001,3238,447,0488,770,9859,604,56310,008,7913,626,2165,785,1272,353,471226,029246,991472,102214,178279,547222,958333,392311,2381,071,9142,963,282600,368324,739340,016618,724549,240690,100643,424805,441711,6321,283,3691,002,477574,581
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,340,196
3,311,099
3,012,595
2,967,177
3,011,870
3,011,8702,967,1773,012,5953,311,0993,340,196000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,448,491
1,321,980
1,241,195
1,498,218
1,392,994
1,311,375
1,432,252
981,766
894,825
775,462
660,590
554,075
453,568
319,335
219,908
106,567
0
0
00106,567219,908319,335453,568554,075660,590775,462894,825981,7661,432,2521,311,3751,392,9941,498,2181,241,1951,321,9801,448,49100000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-902,848
-8,149,915
-198,200
-8,735,449
-16,146,992
-7,489,799
-7,760,666
-396,360
-1,900,000
-1,100,000
-2,567,120
-1,440,840
0
0
0
0
-6,000,000
-6,000,000
-6,000,000
-7,551,480
-7,721,760
-9,068,212
-10,731,394
-5,803,683
196,212
164,254
164,254196,212-5,803,683-10,731,394-9,068,212-7,721,760-7,551,480-6,000,000-6,000,000-6,000,0000000-1,440,840-2,567,120-1,100,000-1,900,000-396,360-7,760,666-7,489,799-16,146,992-8,735,449-198,200-8,149,915-902,848000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-1
-11000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,628,493
489,284
475,298
460,438
445,572
430,690
415,797
400,906
386,013
371,121
356,229
341,337
326,445
159,316
144,424
129,532
114,640
99,748
87,356
79,964
72,572
0
0
0
0
0
0000072,57279,96487,35699,748114,640129,532144,424159,316326,445341,337356,229371,121386,013400,906415,797430,690445,572460,438475,298489,28414,628,493000000000000000000
> Total Stockholder Equity
25,045,247
25,014,937
24,614,068
21,485,970
22,633,299
22,691,098
22,583,638
21,106,486
23,400,022
23,350,804
25,129,886
26,212,434
27,607,165
22,337,788
24,731,363
26,325,509
25,970,446
29,260,871
29,594,485
35,234,781
20,390,077
19,545,577
25,836,082
46,061,506
41,868,513
35,663,440
32,579,552
51,288,344
45,233,345
52,172,965
45,191,123
53,050,020
44,518,175
39,423,742
33,537,037
28,827,564
21,318,537
45,729,871
39,519,554
122,508,362
117,180,798
113,394,871
109,473,134
98,918,426
98,918,426109,473,134113,394,871117,180,798122,508,36239,519,55445,729,87121,318,53728,827,56433,537,03739,423,74244,518,17553,050,02045,191,12352,172,96545,233,34551,288,34432,579,55235,663,44041,868,51346,061,50625,836,08219,545,57720,390,07735,234,78129,594,48529,260,87125,970,44626,325,50924,731,36322,337,78827,607,16526,212,43425,129,88623,350,80423,400,02221,106,48622,583,63822,691,09822,633,29921,485,97024,614,06825,014,93725,045,247
   Common Stock
10,878,434
10,878,434
10,878,434
10,878,434
11,285,600
11,285,600
11,285,600
11,285,600
12,059,504
12,119,063
12,119,063
12,119,063
12,640,983
12,640,983
12,819,660
12,819,660
12,926,866
13,462,292
13,538,406
13,625,394
13,625,394
13,625,394
13,625,394
14,050,920
14,050,920
14,050,920
14,050,920
14,600,156
14,600,156
14,600,155
14,600,156
14,738,346
14,957,430
14,957,430
14,957,430
15,165,763
15,165,763
15,746,032
15,746,032
18,371,456
18,371,456
18,910,661
0
0
0018,910,66118,371,45618,371,45615,746,03215,746,03215,165,76315,165,76314,957,43014,957,43014,957,43014,738,34614,600,15614,600,15514,600,15614,600,15614,050,92014,050,92014,050,92014,050,92013,625,39413,625,39413,625,39413,625,39413,538,40613,462,29212,926,86612,819,66012,819,66012,640,98312,640,98312,119,06312,119,06312,119,06312,059,50411,285,60011,285,60011,285,60011,285,60010,878,43410,878,43410,878,43410,878,434
   Retained Earnings Total Equity00000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,784,216
96,309,083
96,409,737
96,425,913
96,425,913
101,699,058
102,431,537
102,431,537
102,428,398
102,427,008
102,442,648
131,708,140
131,742,653
216,042,575
216,042,575
215,954,368
0
0
00215,954,368216,042,575216,042,575131,742,653131,708,140102,442,648102,427,008102,428,398102,431,537102,431,537101,699,05896,425,91396,425,91396,409,73796,309,08369,784,21600000000000000000000000000
   Treasury Stock0000000000000000000000000000000-608,119-615,808-615,808-615,808-615,808-615,808-615,808-615,808-615,808-691,597-1,177,470-1,218,798-1,217,166
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,704,879
4,466,800
4,470,395
4,939,761
4,902,304
5,062,543
5,300,760
5,519,084
704,260
5,677,023
5,969,887
5,917,138
5,822,862
5,059,499
5,342,951
5,294,027
5,729,978
6,342,530
5,810,155
6,786,880
7,012,165
1,087,233
1,012,732
1,026,704
0
0
001,026,7041,012,7321,087,2337,012,1656,786,8805,810,1556,342,5305,729,9785,294,0275,342,9515,059,4995,822,8625,917,1385,969,8875,677,023704,2605,519,0845,300,7605,062,5434,902,3044,939,7614,470,3954,466,8003,704,879000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,950,930
Cost of Revenue-2,030,287
Gross Profit2,920,6432,920,643
 
Operating Income (+$)
Gross Profit2,920,643
Operating Expense-37,606,219
Operating Income-32,655,289-34,685,576
 
Operating Expense (+$)
Research Development24,907,287
Selling General Administrative3,856,616
Selling And Marketing Expenses0
Operating Expense37,606,21928,763,903
 
Net Interest Income (+$)
Interest Income4,763,689
Interest Expense-406,636
Other Finance Cost-0
Net Interest Income4,357,053
 
Pretax Income (+$)
Operating Income-32,655,289
Net Interest Income4,357,053
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,283,538-32,655,289
EBIT - interestExpense = -406,636
-24,279,526
-23,872,890
Interest Expense406,636
Earnings Before Interest and Taxes (EBIT)0-31,876,902
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-32,283,538
Tax Provision--3,793,758
Net Income From Continuing Ops-28,489,781-28,489,781
Net Income-24,279,526
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-4,357,053
 

Technical Analysis of Oscotec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oscotec. The general trend of Oscotec is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oscotec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oscotec Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 31,300 < 32,800 < 34,200.

The bearish price targets are: 30,000 > 29,800 > 29,800.

Tweet this
Oscotec Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oscotec Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oscotec Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oscotec Inc. The current macd is 1,021.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oscotec price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Oscotec. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Oscotec price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oscotec Inc Daily Moving Average Convergence/Divergence (MACD) ChartOscotec Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oscotec Inc. The current adx is 29.62.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Oscotec shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Oscotec Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oscotec Inc. The current sar is 26,337.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Oscotec Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oscotec Inc. The current rsi is 60.37. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Oscotec Inc Daily Relative Strength Index (RSI) ChartOscotec Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oscotec Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oscotec price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oscotec Inc Daily Stochastic Oscillator ChartOscotec Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oscotec Inc. The current cci is 156.25.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Oscotec Inc Daily Commodity Channel Index (CCI) ChartOscotec Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oscotec Inc. The current cmo is 21.88.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Oscotec Inc Daily Chande Momentum Oscillator (CMO) ChartOscotec Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oscotec Inc. The current willr is -20.3125.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Oscotec is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Oscotec Inc Daily Williams %R ChartOscotec Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oscotec Inc.

Oscotec Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oscotec Inc. The current atr is 1,521.

Oscotec Inc Daily Average True Range (ATR) ChartOscotec Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oscotec Inc. The current obv is 987,232.

Oscotec Inc Daily On-Balance Volume (OBV) ChartOscotec Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oscotec Inc. The current mfi is 65.00.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Oscotec Inc Daily Money Flow Index (MFI) ChartOscotec Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oscotec Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Oscotec Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oscotec Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.372
Ma 20Greater thanMa 5028,437.500
Ma 50Greater thanMa 10026,304.000
Ma 100Greater thanMa 20023,384.500
OpenGreater thanClose30,650.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oscotec with someone you think should read this too:
  • Are you bullish or bearish on Oscotec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oscotec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oscotec Inc

I send you an email if I find something interesting about Oscotec Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Oscotec Inc.

Receive notifications about Oscotec Inc in your mailbox!